Candesartan Cilexetil and Hydrochlorothiazide - candesartan cilexetil and hydrochlorothiazide
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-3002 |
| Proprietary Name: | Candesartan Cilexetil and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | candesartan cilexetil and hydrochlorothiazide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 04-12-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA090704 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 32; 12.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |